z-logo
open-access-imgOpen Access
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapies
Author(s) -
Jeremy Chuang,
Joseph Chao,
Andrew Hendifar,
Samuel J. Klempner,
Jun Gong
Publication year - 2019
Publication title -
translational gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2415-1289
DOI - 10.21037/tgh.2019.08.04
Subject(s) - medicine , subtyping , pembrolizumab , clinical trial , disease , cancer , oncology , intensive care medicine , immunotherapy , computer science , programming language

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom